Home > Archive>Volume 21, Issue 4, 2021 >632-635. DOI:10.3980/j.issn.1672-5123.2021.4.12
PDF HTML XML Export Cite reminder
Progress in the correlation between mucin and ocular surface diseases
Author:
Fund Project:

National Natural Science Foundation of China(No.81660158)

  • Article
    • | |
  • Metrics
    • |
  • Reference [1]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Mucin is the key factor to determine the stability of tear film and is crucial to maintain ocular surface homeostasis. Goblet cells can alter the secretion of mucin in corneal and conjunctival epithelial cells, contributing to dry eye disease and ocular surface inflammation. Based on the understanding of mucin biology, this review makes a summary on the potential relationship between mucin dysfunction and ocular surface diseases, and we hope to deepen the understanding of the importance of mucin and select the most appropriate treatment plan on the basis of ocular surface diseases.

    Reference
    1 Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II Report Executive Summary. Ocul Surf 2017; 15(4):802-812<br>2 刘祖国, 彭娟. 干眼的诊断与治疗规范. 中华实验眼科杂志2008; 26(3):161-164<br>3 Baudouin C, Irkeç M, Messmer EM, et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta Ophthalmol 2018; 96(2):111-119<br>4 Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23:762-770<br>5 Willcox MDP, Argüeso P, Georgiev GA, et al. TFOS DEWS II Tear Film Report. Ocul Surf 2017; 15(3):366-403<br>6 Tseng SC, Hirst LW, Maumenee AE, et al. Possible mechanisms for the loss of GCs in mucin-deficient disorders. Ophthalmology 1984; 91(6):545-552<br>7祁俏然, 沈光林, 马晓萍. 眼表黏蛋白的研究进展及其干眼的相关性. 国际眼科杂志 2016; 16(4):681-685<br>8 Azkargorta M, Soria J, Acera A, et al. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice. J Proteomics 2017; 150:359-367<br>9 Ablamowicz AF, Nichols JJ. Ocular Surface Membrane-Associated Mucins. Ocul Surf 2016; 14(3):331-341<br>10 Baudouin C, Rolando M, Benitez Del Castillo JM, et al. Reconsidering the central role of mucins in dry eye and ocular surface diseases. Prog Retin Eye Res 2019; 71:68-87<br>11 Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol 2016; 16(10):639-649<br>12 Argueso P, Balarm M, Spurr MS, et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci 2002 43(2):1004-1001<br>13 邵毅. 国际干眼新共识(Ⅱ)解读. 眼科新进展 2018; 38(1):1-12<br>14 Caffery B, Heynen ML, Joyce E, et al. MUC1 expression in Sjogren's syndrome, KCS, and control subjects. Mol Vis 2010; 16:1720-1727<br>15 Caffery B, Joyce E, Heynen ML, et al. MUC16 expression in Sjogren's syndrome, KCS, and control subjects. Mol Vis 2008; 14:2547-2555<br>16 Corrales RM, Narayanan S, Fernández I, et al. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci 2011; 52(11):8363-8369<br>17 Gipson IK, Spurr-Michaud SJ, Senchyna M, et al. Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye. Cornea 2011; 30(12):1346-1352<br>18 Occasi F, Duse M, Nebbioso M, et al. Vernal keratoconjunctivitis treated with omalizumab: A case series. Pediatr Allergy Immunol 2017; 28(5):503-505<br>19 Dartt DA, Masli S. Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation. Curr Opin Allergy Clin Immunol 2014; 14(5):464-470<br>20 Leonardi A, Bogacka E, Fauqert JL, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy 2012; 67(11):1327-1337<br>21 Dogru M, Okada N, Asano KN, et al. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin Exp Allergy 2006; 36(12):1556-1565<br>22 Dorgu M, Matsumoto Y, Okada N, et al. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy 2008; 63(10):1324-1334<br>23 Novack GD, Asbell P, Barabino S, et al. TFOS DEWS II Clinical Trial Design Report. Ocul Surf 2017; 15(3):629-649<br>24 Hori Y. Secreted Mucins on the Ocular Surface. Invest Ophthalmol Vis Sci 2018; 59(14):151-156<br>25 Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report [published correction appears in Ocul Surf. 2019 Oct; 17(4):842]. Ocul Surf 2017; 15(3):438-510<br>26 Tanioka H, Yokoi N, Komuro A, et al. Investigation of the corneal filament in filamentary keratitis. Invest Ophthalmol Vis Sci 2009; 50(3):696-702<br>27 Nelson JD. Superior limbic keratoconjunctivitis(SLK). Eye 1989; 3(Pt2): 180-189<br>28 Kuc CJ, Lebow KA. Contact Lens Solutions and Contact Lens Discomfort: Examining the Correlations Between Solution Components, Keratitis, and Contact Lens Discomfort. Eye Contact Lens 2018; 44(6):355-366<br>29 Hori Y, Argueso P, Spurr MS, et al. Mucins and contact lens wear. Cornea 2006; 25(2):176-181<br>30 Colorado LH, Alzahrani Y, Pritchard N, et al. Time Course of Changes in Goblet Cell Density in Symptomatic and Asymptomatic Contact Lens Wearers. Invest Ophthalmol Vis Sci 2016; 57(6): 2888-2894<br>31 Corrales RM, Galarreta D, Herreras JM, et al. Conjunctival mucin mRNA expression in contact lens wear. Optom Vis Sci 2009; 86(9):1051-1058<br>32 Downie LE, Craig JP. Tear film evaluation and management in soft contact lens wear: a systematic approach. Clin Exp Optom 2017; 100(5):438-458<br>33 García-Posadas L, Contreras-Ruiz L, Soriano-Romaní L, et al. Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines. Eye Contact Lens 2016; 42(2):83-90<br>34 Markoulli M, Kolanu S. Contact lens wear and dry eyes: challenges and solutions. Clin Optom(Auckl) 2017; 9:41-48<br>35 邵毅, 石文卿. 2018美国眼科学会干眼指南解读. 眼科新进展 2019; 39(12): 1101-1104<br>36 Pauly A, Brignoie BF, Labbe A, et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci 2007; 48(12):5473-5483<br>37 Rolando M, Brezzo V, Giordano G, et al. The effect of different benzalkonium chloride concentrations on human normal ocular surface. Eye Contact Lens 2018; 44:93-98<br>38 Hung SH, Lee SK, Cristol SM, et al. Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol Vis 2006; 12: 415-421<br>39 Chidambaram JD, Venkatesh Prajna N, Srikanthi P, et al. Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India. Ophthalmic Epidemiol 2018; 25(4):297-305<br>40 Ramadhani AM, Derrick T, Macleod D, et al. Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study. Front Cell Infect Microbiol 2017; 7:406<br>41 Fleiszig SM, Zaidi TS, Ramphal R, et al. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect Immun 1994; 62(5):1799-1804<br>42 Aristoteli LP, Willcox MD. Mucin degradation mechanisms by distinct Pseudomonas aeruginosa isolates in vitro. Infect Immun 2003; 71(10):5565-5575<br>43 Govindarajin B, Menon BB, Spurr MS, et al. A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One 2012:32418<br>44 Bobek LA, Situ H. MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrob Agents Chemother 2003: 47(2): 643-652
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Jia-Xin Peng*, Qiu-Yu Li*,Yi Shao. ,/et al.Progress in the correlation between mucin and ocular surface diseases. Guoji Yanke Zazhi( Int Eye Sci) 2021;21(4):632-635

Copy
Share
Article Metrics
  • Abstract:724
  • PDF: 2872
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:March 11,2020
  • Revised:February 25,2021
  • Online: March 25,2021
You are the 26548 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.